Eli Lilly halts late stage clinical trial

The New York Times looks at the recent drug trial halted by Eli Lilly. The halt of the late stage clinical trial for a potential Alzheimer's treatment because:
The company said patients who had taken the drug, intended to reduce plaque in the brain, actually showed worse cognitive functioning and less ability to perform daily living tasks than patients who had taken a placebo.

This was one of five of Eli Lilly's drugs in late stage clinical trials. To read more about this failed clinical trial, read the article here.

What are the impacts on a company having to pull a high profile drug out of clinical trials?